Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Good morning, and welcome to Elevance Health fourth quarter 2024 earnings call. My name is Nathan Rich, vice president of ...

ELV's fourth-quarter results benefit from rising premiums. However, higher expenses and attrition in Medicaid membership ...

The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall ...

Centene (CNC) stock and Molina Healthcare (MOH) stock were among notable gainers after a Q4 revenue beat from their Medicaid peer, Elevance Health (ELV). Read more here.

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared.

ELV's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.

Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...

Oakmark Equity and Income Fund stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q4 2024 investor letter: “Elevance Health, Inc. (NYSE:ELV) is one of the nation’s largest ...